Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
November 1, 2011
[The neutrophil gelatinase-associated lipocalin, or LCN 2, marker of aggressiveness in clear cell renal cell carcinoma]
C Perrin, J-J Patard, F Jouan, et al.
British Journal of Cancer
|
November 25, 2010
Angiotensin-2 receptors (AT1-R and AT2-R), new prognostic factors for renal clear-cell carcinoma?
T Dolley-Hitze, F Jouan, B Martin, et al.
ESMO Open
|
April 10, 2025
Molecular targeted maintenance therapy versus standard of care in advanced biliary cancer: an international, randomised, controlled, open-label, phase III umbrella trial (SAFIR-ABC10-Precision Medicine)
D Malka, I Borbath, A Lopes, et al.
Clinics and Research in Hepatology and Gastroenterology
|
June 3, 2011
Efficacy of irinotecan in combination with 5-fluorouracil (FOLFIRI) for metastatic gastric or gastroesophageal junction adenocarcinomas (MGA) treatment
E Samalin, P Afchain, S Thézenas, et al.
Cancer Biomarkers : Section a of Disease Markers
|
February 22, 2020
Loss of SMARCB1 expression in colon carcinoma
S Melloul, J-F Mosnier, J Masliah-Planchon, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 25, 2013
Boosted selective internal radiation therapy with 90Y-loaded glass microspheres (B-SIRT) for hepatocellular carcinoma patients: a new personalized promising concept
E Garin, L Lenoir, J Edeline, et al.
JHEP Reports : Innovation in Hepatology
|
March 20, 2026
Liver transplantation in unresectable intrahepatic cholangiocarcinoma following neoadjuvant chemotherapy and SIRT
B Giguet, F Artru, H Jeddou, et al.
ESMO Open
|
September 21, 2021
Trifluridine/tipiracil in combination with oxaliplatin and either bevacizumab or nivolumab in metastatic colorectal cancer: a dose-expansion, phase I study
R Bordonaro, A Calvo, A Auriemma, et al.
Critical Reviews in Oncology/Hematology
|
May 16, 2009
Male breast cancer. Evolution of treatment and prognostic factors. Analysis of 489 cases
B Cutuli, C Cohen-Solal Le-Nir, D Serin, et al.
ESMO Open
|
May 28, 2025
Health-related quality of life analysis of the LEAP-002 study of lenvatinib plus pembrolizumab versus lenvatinib as first-line treatment for advanced hepatocellular carcinoma
R S Finn, M Kudo, P Merle, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
November 1, 2011
[The neutrophil gelatinase-associated lipocalin, or LCN 2, marker of aggressiveness in clear cell renal cell carcinoma]
C Perrin, J-J Patard, F Jouan, et al.
British Journal of Cancer
|
November 25, 2010
Angiotensin-2 receptors (AT1-R and AT2-R), new prognostic factors for renal clear-cell carcinoma?
T Dolley-Hitze, F Jouan, B Martin, et al.
ESMO Open
|
April 10, 2025
Molecular targeted maintenance therapy versus standard of care in advanced biliary cancer: an international, randomised, controlled, open-label, phase III umbrella trial (SAFIR-ABC10-Precision Medicine)
D Malka, I Borbath, A Lopes, et al.
Clinics and Research in Hepatology and Gastroenterology
|
June 3, 2011
Efficacy of irinotecan in combination with 5-fluorouracil (FOLFIRI) for metastatic gastric or gastroesophageal junction adenocarcinomas (MGA) treatment
E Samalin, P Afchain, S Thézenas, et al.
Cancer Biomarkers : Section a of Disease Markers
|
February 22, 2020
Loss of SMARCB1 expression in colon carcinoma
S Melloul, J-F Mosnier, J Masliah-Planchon, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 25, 2013
Boosted selective internal radiation therapy with 90Y-loaded glass microspheres (B-SIRT) for hepatocellular carcinoma patients: a new personalized promising concept
E Garin, L Lenoir, J Edeline, et al.
JHEP Reports : Innovation in Hepatology
|
March 20, 2026
Liver transplantation in unresectable intrahepatic cholangiocarcinoma following neoadjuvant chemotherapy and SIRT
B Giguet, F Artru, H Jeddou, et al.
ESMO Open
|
September 21, 2021
Trifluridine/tipiracil in combination with oxaliplatin and either bevacizumab or nivolumab in metastatic colorectal cancer: a dose-expansion, phase I study
R Bordonaro, A Calvo, A Auriemma, et al.
Critical Reviews in Oncology/Hematology
|
May 16, 2009
Male breast cancer. Evolution of treatment and prognostic factors. Analysis of 489 cases
B Cutuli, C Cohen-Solal Le-Nir, D Serin, et al.
ESMO Open
|
May 28, 2025
Health-related quality of life analysis of the LEAP-002 study of lenvatinib plus pembrolizumab versus lenvatinib as first-line treatment for advanced hepatocellular carcinoma
R S Finn, M Kudo, P Merle, et al.
Page
of 3